Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.5m
Position in Universe th / 6846

BRIEF-Daré Bioscience Enters Into Exclusive Worldwide License Agreement For Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform

Wed 25th April, 2018 1:09pm
April 25 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE, INC. ENTERS INTO EXCLUSIVE WORLDWIDE
LICENSE
AGREEMENT FOR JUNIPER PHARMACEUTICALS’ INTRAVAGINAL RING
(IVR) TECHNOLOGY PLATFORM
    * DARE BIOSCIENCE INC - SECURED EXCLUSIVE LICENSE TO JUNIPER
PHARMACEUTICALS' INTRAVAGINAL RING TECHNOLOGY, INCLUDING
JUNIPER'S 3 PRECLINICAL CANDIDATES

Source text for Eikon:  ID:nGNX84l7dT 
Further company coverage:  DARE.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.